New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A3668

Introduced
2/12/24  

Caption

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Companion Bills

NJ A2544

Carry Over Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Similar Bills

NJ A2544

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

NJ S2143

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

TN SB0421

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN HB1239

AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.

TN SB2297

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

TN HB2308

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to the use of buprenorphine products.

HI HB816

Relating To Emergency Response.

VT H0222

An act relating to reducing overdoses